WallStreetZenWallStreetZen

NASDAQ: EVOK
Evoke Pharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their EVOK stock forecasts and price targets.

Forecast return on equity

Is EVOK forecast to generate an efficient return?

Company
107.12%
Industry
214.68%
Market
340.19%
EVOK's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EVOK forecast to generate an efficient return on assets?

Company
23.01%
Industry
117.5%
EVOK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EVOK earnings per share forecast

What is EVOK's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.92
Avg 2 year Forecast
$0.69
Avg 3 year Forecast
$2.09

EVOK revenue forecast

What is EVOK's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$16.3M+12.95%
Avg 2 year Forecast
$25.7M+78.44%
Avg 3 year Forecast
$36.3M+151.8%
EVOK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EVOK revenue growth forecast

How is EVOK forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
34.56%
Industry
279.36%
Market
58.58%
EVOK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EVOK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EVOK vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
EVOK$10.95N/AN/A
SXTC$1.41N/AN/A
TXMD$1.75N/AN/A
CABR$1.15N/AN/A
AYTU$2.30$9.33+305.78%Strong Buy
View Top Pharmaceutical Stocks

Evoke Pharma Stock Forecast FAQ

What is EVOK's earnings growth forecast for 2025-2027?

(NASDAQ: EVOK) Evoke Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 1,074.97%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 104.45%.

Evoke Pharma's earnings in 2025 is -$5,226,128.On average, 3 Wall Street analysts forecast EVOK's earnings for 2025 to be -$3,302,891, with the lowest EVOK earnings forecast at -$3,173,366, and the highest EVOK earnings forecast at -$3,400,035. On average, 3 Wall Street analysts forecast EVOK's earnings for 2026 to be $1,194,663, with the lowest EVOK earnings forecast at $1,147,813, and the highest EVOK earnings forecast at $1,229,800.

In 2027, EVOK is forecast to generate $3,601,557 in earnings, with the lowest earnings forecast at $3,460,320 and the highest earnings forecast at $3,707,485.

If you're new to stock investing, here's how to buy Evoke Pharma stock.

What is EVOK's revenue growth forecast for 2025-2027?

(NASDAQ: EVOK) Evoke Pharma's forecast annual revenue growth rate of 34.56% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 279.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.58%.

Evoke Pharma's revenue in 2025 is $14,424,652.On average, 3 Wall Street analysts forecast EVOK's revenue for 2025 to be $28,061,487, with the lowest EVOK revenue forecast at $26,962,590, and the highest EVOK revenue forecast at $28,888,244. On average, 3 Wall Street analysts forecast EVOK's revenue for 2026 to be $44,334,808, with the lowest EVOK revenue forecast at $42,595,175, and the highest EVOK revenue forecast at $45,638,671.

In 2027, EVOK is forecast to generate $62,559,617 in revenue, with the lowest revenue forecast at $60,106,907 and the highest revenue forecast at $64,399,150.

What is EVOK's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: EVOK) forecast ROA is 23.01%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 117.5%.

What is EVOK's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: EVOK) Evoke Pharma's current Earnings Per Share (EPS) is -$1.38. On average, analysts forecast that EVOK's EPS will be -$1.92 for 2025, with the lowest EPS forecast at -$1.84, and the highest EPS forecast at -$1.97. On average, analysts forecast that EVOK's EPS will be $0.69 for 2026, with the lowest EPS forecast at $0.67, and the highest EPS forecast at $0.71. In 2027, EVOK's EPS is forecast to hit $2.09 (min: $2.01, max: $2.15).

What is EVOK's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: EVOK) forecast ROE is 107.12%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.